Commitment to achieving net zero
Swedish Orphan Biovitrum Ltd (“Sobi”) is the UK subsidiary of Swedish Orphan Biovitrum AB, the parent company of the Sobi Group, headquartered in Stockholm, Sweden. The Sobi organisation spans more than 30 countries, delivering treatments to patients in over 70 countries across the globe.
As our parent-company is based within the European Union (EU), Sobi AB has an obligation to set and drive targets that are aligned with the Paris 1.5°C target to achieve net neutrality for the entire Group by 2050. Our long-term ambition is to reduce our operational GHG footprint (Scope 1 and 2) to net zero emissions by 2030. During 2024 Sobi AB will set targets also for some Scope 3 categories.
The UK subsidiary, Sobi Ltd, is separately committed to achieving net zero emissions within the UK by 2050.
Sobi Emissions Footprint
Baseline emissions are a record of the greenhouse gases (GHG) that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions.
Baseline emissions are the reference point against which emissions reduction can be measured.
Sobi’s baseline GHG emissions in tonnes CO2
Scope 1 and 2 baseline year: 2016 |
|
Scope 1: Direct emissions from Sobi’s own operations |
435 |
Scope 2: Indirect emissions from Sobi’s own operations |
1,157 |
Scope 3: Subset of other indirect emissions that occur in Sobi’s value chain+ |
17,587* |
* Scope 3 data shown from 2022 for reference. Sobi AB is in the process of reviewing its targets and will in this process update its base year for scope 3 emissions.
+ Subset relates to - upstream transportation and distribution; waste generated in operations; business travel; employee commuting; and downstream transportation and distribution.
Sobi’s current GHG emissions in tonnes CO2
Reporting year: 2023 |
|
Scope 1: Direct emissions from Sobi’s own operations |
904 |
Scope 2: Indirect emissions from Sobi’s own operations |
648 |
Scope 3: Subset of other indirect emissions that occur in Sobi’s value chain* |
18,747 |
* Subset relates to - upstream transportation and distribution; waste generated in operations; business travel; employee commuting; and downstream transportation and distribution.
Carbon Reduction Projects
Sobi’s emissions from scope 1 and 2 have decreased by 2.5% by end of 2023 compared to our baseline year of 2016. Our total scope 1 and 2 emissions per employee (tonnes per FTE) also reduced from 2.09 in 2016 to 0.88 in 2023.
Sobi remains committed to reducing our emissions and achieving net zero emissions within the UK by 2050. Our carbon footprint is mainly caused by energy consumption in pharmaceutical manufacturing, business travel, supply chain logistics and the distribution of medicines. Environmental impacts from production and laboratories are mainly due to the use of energy, water and chemicals, waste generated and sewage discharge.
Reduction of water and energy consumption, chemicals, waste and emissions has been prioritised in Sobi’s production and laboratory facilities. Specific and detailed environmental guidance for the facilities has been given in specific standard operating procedures (SOPs) and in our environmental compliance programme, to improve the control of the environmental impact of production. Energy and water consumption at Sobi’s production facility has continuously been assessed to improve environmental performance.
In the UK, Sobi has increased the amount of renewable energy we buy. We source 100% renewable energy for our UK office. Other recently introduced UK programmes include reducing the volume and distance to travel for meetings as well as an electric and hybrid car scheme for UK employees.
More details on our global metrics, projects and performance related to climate and energy can be found in the sections Reducing environmental footprint and Responsible Sourcing as well as in the section Sustainability notes of our ‘Annual and Sustainability Report 2023’, available here.
Declaration and Sign Off
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard1 and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.2
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.3
This Carbon Reduction Plan has been reviewed and signed off by the UK company director.
Signed on behalf of Sobi Ltd
………………………………………………………………………..
Sharon Hall
Vice President & General Manager, UK & Republic of Ireland UK & Ireland
Date: September 2024
Sep, 2024